Clinical Trial Update: An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED) [Phase 3]

View source ↗

Summary

The extension study (0653A-038) of an investigational drug for hypercholesterolemia has completed, with Organon and Co listed as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Investigational drug (0653A-038)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED